Logo Image
News
Academy
Publications
All PublicationsE-Books
Media
Editorial PodcastsEditorial VideosPeer ExchangePractice AcademyShortsSponsored PodcastsSponsored Videos
More
Conferences
Conference CoverageConference Listing
Columns
All ColumnsA Closing ThoughtClinical Trial InsightsView from BrusselsView from Washington
Resources
AdvertiseBlogsEventsFront & CenterPartner PerspectivesWhite Papers
Events
Webcasts
Event Calendar

Subscribe

  • News
  • Academy
  • Publications
  • Media
  • Conferences
  • Columns
  • Resources
  • Events
  • Subscribe
  • Event Calendar
  • Clinical Operations & Strategy
    • Decentralized Clinical Trials
    • Trial Design
    • Investigative Sites
    • CRO/Sponsor
    • Risk-Based Monitoring
    • Protocol Design
    • Clinical Trial Supply Chain
    • Study Start-Up
    • Early Phase Development
  • DEI
    • Industry Initiatives
    • Diversity Action Plans
    • Recruitment
  • Data Management
    • Analytics
    • Electronic Data Capture
    • Real World Evidence
    • Metrics & Benchmarks
  • Patient Participation
    • Integrated Research
    • CRAACO
    • Enrollment
  • Regulatory
    • Institutional Review Board & Ethics Committee
    • FDA
    • EMA
  • Technology
    • Artificial Intelligence/Machine Learning
    • eClinical
    • mHealth
Spotlight -
Conference Coverage|
Peer Exchange|
DE&I|
Editorial Videos|
Clinical Operations & Strategy|
Patient Participation
Advertisement

Pharmaceutical Executive

Advertisement

Articles by Pharmaceutical Executive

Who's the More Innovative: CROs or Pharma?

ByPharmaceutical Executive
June 20th 2012

Applied Clinical Trials

ClaytonChristensen-774771-1408603366908.jpg

Clayton Christensen on the Future of Pharma

ByPharmaceutical Executive
May 25th 2012

Applied Clinical Trials

Too Much Sauce Hollandaise? Pharma, France, and Socialism

ByPharmaceutical Executive
May 25th 2012

Applied Clinical Trials

Donald-772396-1408605614929.png

CETP Inhibitors: Blockbusters that Never Ran?

ByPharmaceutical Executive
May 7th 2012

Applied Clinical Trials

US Biosimilars Under Threat?

ByPharmaceutical Executive
May 2nd 2012

Applied Clinical Trials

Advertisement

Latest Updated Articles

  • Donald-772396-1408605614929.png
    CETP Inhibitors: Blockbusters that Never Ran?

    May 7th 2012

  • US Biosimilars Under Threat?
    US Biosimilars Under Threat?

    May 2nd 2012

  • ClaytonChristensen-774771-1408603366908.jpg
    Clayton Christensen on the Future of Pharma

    May 25th 2012

  • Too Much Sauce Hollandaise? Pharma, France, and Socialism
    Too Much Sauce Hollandaise? Pharma, France, and Socialism

    May 25th 2012

  • Who's the More Innovative: CROs or Pharma?
    Who's the More Innovative: CROs or Pharma?

    June 20th 2012



Advertisement
Advertisement

Trending on Applied Clinical Trials Online

1

Tailoring Your FSP Approach: Why One Model Doesn’t Fit Every Trial

2

ACT Brief: Multimodal AI Systems Architecture, Trust-Based Trial Recruitment, and Big Pharma AI Transformation

3

FDA Pauses Real-Time Release of Drug Rejection Letters While Working to Formalize Policy

4

Bringing the Voice of Clinical Practice and Patients into Drug Development

5

ACT Brief: Single Pivotal Trial Stakes, Configurable FSP Strategy, and G-CSF Biosimilar Portfolio Expansion

  • About
  • Advertise
  • Contact Us
  • Editorial Contacts
  • Do Not Sell My Personal Information
  • Privacy Policy
  • Terms and Conditions
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

  • Applied Clinical Trials
  • BioPharm International
  • Cannabis Science and Technology
  • Chromatography Online
  • Nutritional Outlook
  • Pharmaceutical Commerce
  • Pharmaceutical Executive
  • Pharm Tech
  • Spectroscopy Online
  • Turbo Machinery Magazine
IS1
Brand Logo

© 2026 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us